BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively. BDTX-189 exhibits anticancer activity.
Molecular Weight:
561.03
Purity:
>99%
CAS Number:
[2414572-47-5]
Formula:
C29H29ClN6O4
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
